Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 30, 2019 - Issue 1
Submit an article Journal homepage
4,830
Views
20
CrossRef citations to date
0
Altmetric
Psoriasis and atopic dermatitis

Efficacy and safety of ixekizumab in patients with plaque psoriasis across different degrees of disease severity: results from UNCOVER-2 and UNCOVER-3

Lajos KeményMTA SZTE Dermatological Research Group, University of Szeged, Szeged, Hungary; ;Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary; Correspondence[email protected]
View further author information
,
Lovisa BerggrenLilly Deutschland GmbH, Bad Homburg, Germany; View further author information
,
Martin DossenbachLilly Deutschland GmbH, Bad Homburg, Germany; View further author information
,
Yves DutroncEli Lilly and Company, Indianapolis, IN, USA; View further author information
&
Carle PaulDepartment of Dermatology, Paul Sabatier University and CHU Toulouse, Toulouse, FranceView further author information
Pages 19-26 | Received 10 Apr 2018, Accepted 24 Apr 2018, Published online: 12 Jun 2018

Related Research Data

Efficacy and safety of ixekizumab in patients with plaque psoriasis across different degrees of disease severity: results from UNCOVER-2 and UNCOVER-3
Source: Figshare
Efficacy and safety of ixekizumab in patients with plaque psoriasis across different degrees of disease severity: results from UNCOVER-2 and UNCOVER-3
Source: Figshare

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.